BRPI0924398A2 - perexilina, metodo de tratamento de hfnef e programa de tratamento para tratar hfnef - Google Patents

perexilina, metodo de tratamento de hfnef e programa de tratamento para tratar hfnef

Info

Publication number
BRPI0924398A2
BRPI0924398A2 BRPI0924398A BRPI0924398A BRPI0924398A2 BR PI0924398 A2 BRPI0924398 A2 BR PI0924398A2 BR PI0924398 A BRPI0924398 A BR PI0924398A BR PI0924398 A BRPI0924398 A BR PI0924398A BR PI0924398 A2 BRPI0924398 A2 BR PI0924398A2
Authority
BR
Brazil
Prior art keywords
hfnef
treatment
perexillin
treating
treatment method
Prior art date
Application number
BRPI0924398A
Other languages
English (en)
Inventor
Ashrafian Houman
Paul Frenneaux Michael
Original Assignee
Heart Metabolics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heart Metabolics Ltd filed Critical Heart Metabolics Ltd
Publication of BRPI0924398A2 publication Critical patent/BRPI0924398A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
BRPI0924398A 2009-05-20 2009-05-20 perexilina, metodo de tratamento de hfnef e programa de tratamento para tratar hfnef BRPI0924398A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB2009/050539 WO2010133815A1 (en) 2009-05-20 2009-05-20 Treatment of heart failure with normal ejection fraction

Publications (1)

Publication Number Publication Date
BRPI0924398A2 true BRPI0924398A2 (pt) 2019-09-24

Family

ID=41213178

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0924398A BRPI0924398A2 (pt) 2009-05-20 2009-05-20 perexilina, metodo de tratamento de hfnef e programa de tratamento para tratar hfnef

Country Status (11)

Country Link
US (3) US8440697B2 (pt)
EP (1) EP2432470A1 (pt)
JP (1) JP2012527438A (pt)
CN (1) CN102573844A (pt)
AU (1) AU2009346606B2 (pt)
BR (1) BRPI0924398A2 (pt)
CA (1) CA2816448A1 (pt)
IL (1) IL216362A0 (pt)
MX (1) MX2011012310A (pt)
WO (1) WO2010133815A1 (pt)
ZA (1) ZA201109332B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405381D0 (en) 2004-03-10 2004-04-21 Univ Wales Medicine A method and means for treating heart failure
WO2010133815A1 (en) 2009-05-20 2010-11-25 Heart Metabolics Limited Treatment of heart failure with normal ejection fraction
GB0908193D0 (en) 2009-05-13 2009-06-24 Albright Patents Treatment of disease state
US10137093B2 (en) 2011-08-16 2018-11-27 Cardiora Pty Ltd. Milrinone controlled-release formulation
WO2014036603A1 (en) * 2012-09-05 2014-03-13 Adelaide Research & Innovation Pty Ltd Uses of (-)-perhexiline
BR112017013015A2 (pt) * 2014-12-22 2018-03-06 Cardiora Pty Ltd método de tratamento de um paciente que possui falência cardíaca com fração de ejeção preservada (hfpef)
MX2019007125A (es) 2016-12-15 2019-09-16 Baxter Int Sistema y metodo para monitorizar y determinar parametros de paciente a partir de forma de onda venosa detectada.
US11039754B2 (en) 2018-05-14 2021-06-22 Baxter International Inc. System and method for monitoring and determining patient parameters from sensed venous waveform

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN380695A0 (en) 1995-06-23 1995-07-20 Queen Elizabeth Hospital, The Methods related to the treatment of and isolation of compounds for treatment of ischaemic conditions
US20030162824A1 (en) 2001-11-12 2003-08-28 Krul Elaine S. Methods of treating or preventing a cardiovascular condition using a cyclooxygenase-1 inhibitor
CL2004000366A1 (es) 2003-02-26 2005-01-07 Pharmacia Corp Sa Organizada B USO DE UNA COMBINACION DE UN COMPUESTO DERIVADO DE PIRAZOL INHIBIDOR DE QUINASA p38, Y UN INHIBIDOR DE ACE PARA TRATAR DISFUNCION RENAL, ENFERMEDAD CARDIOVASCULAR Y VASCULAR, RETINOPATIA, NEUROPATIA, EDEMA, DISFUNCION ENDOTELIAL O INSULINOPATIA.
GB0405381D0 (en) 2004-03-10 2004-04-21 Univ Wales Medicine A method and means for treating heart failure
WO2005097121A1 (en) 2004-04-06 2005-10-20 Angiogenetics Sweden Ab Angiogenesis-affecting compounds and methods of use thereof
DE602006011363D1 (de) 2005-12-01 2010-02-04 Hoffmann La Roche Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
ITRM20060090A1 (it) 2006-02-22 2007-08-23 Sigma Tau Ind Farmaceuti Nuovi composti inibitori cpt a livello del snc come farmaci antidiabetici e o antiobesita
WO2010133815A1 (en) 2009-05-20 2010-11-25 Heart Metabolics Limited Treatment of heart failure with normal ejection fraction
GB0723100D0 (en) * 2007-11-23 2008-01-02 Heart Metabolics Ltd Treatment of HFnEF
GB0908193D0 (en) 2009-05-13 2009-06-24 Albright Patents Treatment of disease state
US20140019207A1 (en) 2012-07-11 2014-01-16 Sap Ag Interactive in-memory based sales forecasting
WO2014036603A1 (en) 2012-09-05 2014-03-13 Adelaide Research & Innovation Pty Ltd Uses of (-)-perhexiline
WO2015131231A1 (en) 2014-03-03 2015-09-11 Adelaide Research & Innovation Pty Ltd Methods for using (-)-perhexiline

Also Published As

Publication number Publication date
ZA201109332B (en) 2012-08-29
AU2009346606B2 (en) 2016-06-02
US8440697B2 (en) 2013-05-14
US20130210719A1 (en) 2013-08-15
JP2012527438A (ja) 2012-11-08
EP2432470A1 (en) 2012-03-28
CA2816448A1 (en) 2010-11-25
IL216362A0 (en) 2012-01-31
US9468634B2 (en) 2016-10-18
US20130210720A1 (en) 2013-08-15
US20100331364A1 (en) 2010-12-30
MX2011012310A (es) 2012-04-11
WO2010133815A1 (en) 2010-11-25
CN102573844A (zh) 2012-07-11
AU2009346606A1 (en) 2012-01-19
US9457017B2 (en) 2016-10-04

Similar Documents

Publication Publication Date Title
BRPI1007477A2 (pt) método, e, composição de tratamento de poço
BRPI0912337A2 (pt) composto método para melhorar memória em paciente, e, método para tratar condições
BRPI0916472A2 (pt) dispositivo de tratamento de ferimento, método para tratamento de um ferimento e dispositivo de tratamento de ferimento
BRPI1009598A2 (pt) aparelho para redução do ronco, método para redução do ronco e programa de computador para redução do ronco
BRPI1011795A2 (pt) método e aparelho para tratamento de pele fracional.
PT2250275T (pt) Aparelho e método para tratar resíduos
BRPI0815283A2 (pt) Equipamento para o tratamento da biomassa, método para o tratamento da biomassa, biomassa tratada e hidrolisado
PT2528699T (pt) Aparelho e processo para tratamento de resíduos
PT2434891T (pt) Métodos para tratamento de cancro e afeções não neoplásicas
BRPI1007779A2 (pt) perexilina, método para tratamento de hcm, programa de tratamento para tratar hcm e uso da perexilina
BR112012028514A2 (pt) composição para o tratamento da água residual e processo para o tratamento de água residual
BRPI1013878A2 (pt) método para tratar distúrbios metabólicos, e, composto
BRPI0911077A2 (pt) método para tratamento de biomassa
BR112013016491A2 (pt) método para tratamento de têxtil
BR112012000025A2 (pt) polipeptídos e processo de tratamento.
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BR112013004456A2 (pt) composição para tratamento de planta, e, método para o tratamento de plantas
BRPI1005680A2 (pt) aparelho e método de processamento de imagem, e, programa para processamento de imagem
BRPI1013219A2 (pt) método para o alvejamento-branqueamento enzimático têxtil
BRPI0909164A2 (pt) método e composições para o tratamento de câncer
BR112014004192A2 (pt) composição de tratamento de sementes, e, método de tratamento de sementes
BRPI1013361A2 (pt) método para evitar e tratar hipermeabilidade.
BR112012008229A2 (pt) método, e aparelho
BRPI0919587A2 (pt) método para documentar tratamento de animal, e , produto de software
BR112014016108A2 (pt) método de tratamento de perda óssea alvelar

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.